Cardinal Health Inc
$ 208.29
0.36%
26 Dec - close price
- Market Cap 49,488,671,000 USD
- Current Price $ 208.29
- High / Low $ 208.44 / 207.11
- Stock P/E 31.46
- Book Value -12.10
- EPS 6.62
- Next Earning Report 2026-01-29
- Dividend Per Share $2.03
- Dividend Yield 0.98 %
- Next Dividend Date 2026-01-15
- ROA 0.03 %
- ROE N/A %
- 52 Week High 214.93
- 52 Week Low 115.86
About
Cardinal Health, Inc. is a prominent player in the global healthcare supply chain, providing essential pharmaceuticals and medical products tailored to enhance patient care and optimize operations for healthcare providers and manufacturers. With a robust commitment to innovation, Cardinal Health integrates advanced data analytics and medication management solutions, paving the way for improved healthcare delivery. The company's extensive logistical capabilities and strategic partnerships position it as a vital contributor to the efficiency and effectiveness of the evolving healthcare landscape, making it an attractive option for institutional investors seeking stability and growth in the sector.
Analyst Target Price
$216.60
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-31 | 2025-08-12 | 2025-05-01 | 2025-01-30 | 2024-11-01 | 2024-08-14 | 2024-05-02 | 2024-02-01 | 2023-11-03 | 2023-08-15 | 2023-05-04 | 2023-02-02 |
| Reported EPS | 2.55 | 2.08 | 2.35 | 1.93 | 1.88 | 1.84 | 2.08 | 1.82 | 1.73 | 1.55 | 1.74 | 1.32 |
| Estimated EPS | 2.18 | 2.03 | 2.15 | 1.76 | 1.62 | 1.73 | 1.95 | 1.6 | 1.4 | 1.49 | 1.49 | 1.14 |
| Surprise | 0.37 | 0.05 | 0.2 | 0.17 | 0.26 | 0.11 | 0.13 | 0.22 | 0.33 | 0.06 | 0.25 | 0.18 |
| Surprise Percentage | 16.9725% | 2.4631% | 9.3023% | 9.6591% | 16.0494% | 6.3584% | 6.6667% | 13.75% | 23.5714% | 4.0268% | 16.7785% | 15.7895% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-01-29 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 2.31 |
| Currency | USD |
Previous Dividend Records
| Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-01-15 | 2025-10-15 | 2025-07-15 | 2025-04-15 | 2025-01-15 | 2024-10-15 | 2024-07-15 | 2024-04-15 | 2024-01-15 | 2023-10-15 |
| Amount | $0.5107 | $0.5107 | $0.5107 | $0.5056 | $0.5056 | $0.5056 | $0.5056 | $0.5006 | $0.5006 | $0.5006 |
Next Dividend Records
| Dividend per share (year): | $2.03 |
| Dividend Yield | 0.98% |
| Next Dividend Date | 2026-01-15 |
| Ex-Dividend Date | 2026-01-02 |
Recent News: CAH
2025-12-29 16:28:23
The U.S. Embolic Protection Device Market is projected to grow from US$360 million in 2024 to US$650 million by 2033, with a CAGR of 6.96%. This growth is primarily driven by the increasing prevalence of cardiovascular diseases, an aging population, and technological advancements in device design. Key challenges include the high cost of devices and complexities in reimbursement, as well as the need for highly skilled operators to properly use these devices.
2025-12-29 14:52:45
Worldwide Market Reports has released a new study predicting substantial growth for the "Patient Liaison Assistance Market." The report offers a comprehensive analysis of market dynamics, competitive landscape including key players like McKesson and Cardinal Health, and segmental highlights by types and applications. It also provides regional insights, research methodology, and actionable intelligence to support business growth and investment decisions.
2025-12-29 11:00:25
Sowell Financial Services LLC reduced its stake in Cardinal Health, Inc. (NYSE:CAH) by 39.3%, selling 9,987 shares and retaining 15,419 shares valued at approximately $2.42 million. This move comes as Cardinal Health recently surpassed quarterly earnings expectations and provided strong FY2026 guidance, leading to several analyst target increases and a consensus "Moderate Buy" rating. The company also declared a quarterly dividend of $0.5107, payable on January 15th to shareholders of record on January 2nd.
2025-12-28 13:36:22
Vontobel Holding Ltd. significantly reduced its stake in Cardinal Health, Inc. (NYSE:CAH) by 83.9% in Q3, selling 33,101 shares and retaining 6,370 shares valued at approximately $1.0 million. Despite this sale, Wall Street analysts maintain a generally positive outlook with an average target price of $209.00 and numerous "buy" ratings. Cardinal Health also reported strong Q3 earnings, beating estimates with $2.55 EPS and generating $64.01 billion in revenue, and announced a quarterly dividend of $0.5107.
2025-12-28 12:12:59
Cardinal Health (NYSE:CAH) is poised to go ex-dividend soon, offering a dividend payment of US$0.5107 per share, contributing to a 1.0% trailing yield. The company demonstrates strong dividend sustainability with a modest payout ratio of 31% from profit and 11% from free cash flow, alongside robust earnings growth of 23% per annum over the past five years. This favorable combination of rapid earnings growth, low payout ratios, and consistent dividend increases suggests Cardinal Health is a solid choice for dividend-focused investors.
2025-12-28 12:08:08
Cardinal Health, Inc. (NYSE:CAH) is set to trade ex-dividend shortly, with a payment of US$0.5107 per share expected on January 15th. The company exhibits a conservative payout ratio of 31% of profit and 11% of free cash flow, suggesting a sustainable dividend. With rapid earnings per share growth of 23% annually over the last five years, Cardinal Health presents an appealing option for dividend investors.
